ReP USP - Resultado da busca

Artigo de periodico
Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? (2020)
Amorim, Viviane Brandão ; Parente, Daniella Braz ; Paiva, Fernando Fernandes ; Oliveira Neto, Jaime Araújo ; Miranda, Amanda Almeida ; Moreira, Cláudia Cravo ; Fernandes, Flávia Ferreira ; Campos, Carlos Frederico Ferreira; Leite, Nathalie Carvalho ; Perez, Renata de Mello ; Rodrigues, Rosana Souza
Source: World Journal of Hepatology. Unidade: IFSC
Subjects: OBESIDADE, FÍGADO GORDUROSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMORIM, Viviane Brandão et al. Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?. World Journal of Hepatology, v. 12, n. 9, p. 661-671, 2020Tradução . . Disponível em: https://doi.org/10.4254/wjh.v12.i9.661. Acesso em: 07 jun. 2024.
APA
Amorim, V. B., Parente, D. B., Paiva, F. F., Oliveira Neto, J. A., Miranda, A. A., Moreira, C. C., et al. (2020). Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World Journal of Hepatology, 12( 9), 661-671. doi:10.4254/wjh.v12.i9.661
NLM
Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez R de M, Rodrigues RS. Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? [Internet]. World Journal of Hepatology. 2020 ; 12( 9): 661-671.[citado 2024 jun. 07 ] Available from: https://doi.org/10.4254/wjh.v12.i9.661
Vancouver
Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez R de M, Rodrigues RS. Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? [Internet]. World Journal of Hepatology. 2020 ; 12( 9): 661-671.[citado 2024 jun. 07 ] Available from: https://doi.org/10.4254/wjh.v12.i9.661
Artigo de periodico
Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study (2020)
Parente, Daniellla Braz; Perazzo, Hugo; Paiva, Fernando Fernandes ; Campos, Carlos Frederico Ferreira; Saboya, Carlos José; Pereira, Silvia Elaine; Silva, Felipe d'Almeida e; Rodrigues, Rosana Souza; Perez, Renata de Mello
Source: Scientific Reports. Unidade: IFSC
Subjects: OBESIDADE, FÍGADO GORDUROSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARENTE, Daniellla Braz et al. Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study. Scientific Reports, v. 10, p. 15007-1-15007-9, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-71723-2. Acesso em: 07 jun. 2024.
APA
Parente, D. B., Perazzo, H., Paiva, F. F., Campos, C. F. F., Saboya, C. J., Pereira, S. E., et al. (2020). Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study. Scientific Reports, 10, 15007-1-15007-9. doi:10.1038/s41598-020-71723-2
NLM
Parente DB, Perazzo H, Paiva FF, Campos CFF, Saboya CJ, Pereira SE, Silva F d'A e, Rodrigues RS, Perez R de M. Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study [Internet]. Scientific Reports. 2020 ; 10 15007-1-15007-9.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1038/s41598-020-71723-2
Vancouver
Parente DB, Perazzo H, Paiva FF, Campos CFF, Saboya CJ, Pereira SE, Silva F d'A e, Rodrigues RS, Perez R de M. Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study [Internet]. Scientific Reports. 2020 ; 10 15007-1-15007-9.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1038/s41598-020-71723-2
Artigo de periodico
Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes (2018)
Parente, Daniella Braz; Oliveira Neto, Jaime Araújo; Brasil, Pedro Emmanuel Alvarenga Americano; Paiva, Fernando Fernandes; Ravani, José Pedro Rodrigues; Gomes, Marilia Brito; Lanzoni, Valeria; Campos, Carlos Frederico Ferreira; Machado-Silva, Lilian; Perez, Renata Mello; Rodrigues, Rosana Souza
Source: Journal of Gastroenterology and Hepatology. Unidade: IFSC
Subjects: IMAGEM POR RESSONÂNCIA MAGNÉTICA, EPILEPSIA, NEUROCIÊNCIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARENTE, Daniella Braz et al. Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes. Journal of Gastroenterology and Hepatology, v. 33, n. 2, p. 511-517 , 2018Tradução . . Disponível em: https://doi.org/10.1111/jgh.13903. Acesso em: 07 jun. 2024.
APA
Parente, D. B., Oliveira Neto, J. A., Brasil, P. E. A. A., Paiva, F. F., Ravani, J. P. R., Gomes, M. B., et al. (2018). Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes. Journal of Gastroenterology and Hepatology, 33( 2), 511-517 . doi:10.1111/jgh.13903
NLM
Parente DB, Oliveira Neto JA, Brasil PEAA, Paiva FF, Ravani JPR, Gomes MB, Lanzoni V, Campos CFF, Machado-Silva L, Perez RM, Rodrigues RS. Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes [Internet]. Journal of Gastroenterology and Hepatology. 2018 ; 33( 2): 511-517 .[citado 2024 jun. 07 ] Available from: https://doi.org/10.1111/jgh.13903
Vancouver
Parente DB, Oliveira Neto JA, Brasil PEAA, Paiva FF, Ravani JPR, Gomes MB, Lanzoni V, Campos CFF, Machado-Silva L, Perez RM, Rodrigues RS. Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes [Internet]. Journal of Gastroenterology and Hepatology. 2018 ; 33( 2): 511-517 .[citado 2024 jun. 07 ] Available from: https://doi.org/10.1111/jgh.13903
Artigo de periodico
Intravoxel incoherent motion diffusion weighted MR imaging at 3.0 T: assessment of steatohepatitis and fibrosis compared with liver biopsy in type 2 diabetic patients (2015)
Parente, Daniella Braz; Paiva, Fernando Fernandes; Oliveira Neto, Jaime Araújo; Silva, Lilian Machado; Figueiredo, Fatima Aparecida Ferreira; Lanzoni, Valeria; Campos, Carlos Frederico Ferreira; Brasil, Pedro Emmanuel Alvarenga Americano do; Gomes, Marilia de Brito; Perez, Renata de Mello; Rodrigues, Rosana Souza
Source: PLOS ONE. Unidade: IFSC
Subjects: DIABETES MELLITUS, RESSONÂNCIA MAGNÉTICA, ESPECTROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARENTE, Daniella Braz et al. Intravoxel incoherent motion diffusion weighted MR imaging at 3.0 T: assessment of steatohepatitis and fibrosis compared with liver biopsy in type 2 diabetic patients. PLOS ONE, v. 10, n. 5 , p. e0125653-1-e0125653-13, 2015Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0125653. Acesso em: 07 jun. 2024.
APA
Parente, D. B., Paiva, F. F., Oliveira Neto, J. A., Silva, L. M., Figueiredo, F. A. F., Lanzoni, V., et al. (2015). Intravoxel incoherent motion diffusion weighted MR imaging at 3.0 T: assessment of steatohepatitis and fibrosis compared with liver biopsy in type 2 diabetic patients. PLOS ONE, 10( 5 ), e0125653-1-e0125653-13. doi:10.1371/journal.pone.0125653
NLM
Parente DB, Paiva FF, Oliveira Neto JA, Silva LM, Figueiredo FAF, Lanzoni V, Campos CFF, Brasil PEAA do, Gomes M de B, Perez R de M, Rodrigues RS. Intravoxel incoherent motion diffusion weighted MR imaging at 3.0 T: assessment of steatohepatitis and fibrosis compared with liver biopsy in type 2 diabetic patients [Internet]. PLOS ONE. 2015 ;10( 5 ): e0125653-1-e0125653-13.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1371/journal.pone.0125653
Vancouver
Parente DB, Paiva FF, Oliveira Neto JA, Silva LM, Figueiredo FAF, Lanzoni V, Campos CFF, Brasil PEAA do, Gomes M de B, Perez R de M, Rodrigues RS. Intravoxel incoherent motion diffusion weighted MR imaging at 3.0 T: assessment of steatohepatitis and fibrosis compared with liver biopsy in type 2 diabetic patients [Internet]. PLOS ONE. 2015 ;10( 5 ): e0125653-1-e0125653-13.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1371/journal.pone.0125653

USP Schools

ReP

Filtros

Authors

Subjects